What You Should Know:
2bPrecise, a precision medicine company, announced that the US Orthopedic Alliance (USOA) is leveraging 2bPrecise’ pharmacogenomics (PGx) solution to help physicians identify potentially dangerous drug-gene interactions.
- The 2bPrecise platform will deliver workflow, data management and clinical decision functionality to USOA providers ordering pharmacogenomic tests (PGx). Specifically, doctors can leverage test results to make informed decisions
Read More
Life Sciences | News, Analysis, Insights - HIT Consultant
UPS Healthcare Expands Specialty Pharmaceutical Offerings with End-to-End Cold Chain Capabilities
What You Should Know:
- UPS Healthcare today announced it is enhancing its specialty pharmaceutical offerings by establishing UPS Cold Chain Solutions, a comprehensive suite of cold chain technologies, best-in-class capabilities to support healthcare customers.
- UPS Cold Chain Solutions is purpose-built to provide pharmaceutical companies, healthcare providers and laboratories a full, end-to-end cold chain service offering, including storage and distribution,
Read More
AcuityMD Nabs $7M for Targeting Platform for Medical Device Companies
What You Should Know:
- AcuityMD, a platform for commercializing and improving medical devices with data announced it has raised $7M in funding led by Benchmark with participation from Ajax Health. Eric Vishria, General Partner at Benchmark will also join AcuityMD’s board of directors.
- Since launching commercially in 2020, AcuityMD has become a trusted partner within the medical device industry by creating a data platform for the entire medical device lifecycle, from sale and
Read More
CVS Health Launches Clinical Trial Services Business for Investigational COVID-19 Vaccines & Treatments
What You Should Know:
- Today, CVS Health announced the launch of a new Clinical Trial Services business, driving greater access to clinical trials across the communities CVS Health serves and creating a more efficient, convenient experience to improve participant retention and research effectiveness.
- CVS Health collaborated with the pharmaceutical industry to help facilitate clinical trials for investigational COVID-19 vaccines and treatments. Using a specially designed
Read More
Cue Health Raises $235M to Scale Connected, Molecular Diagnostic System
What You Should Know:
- Cue Health Inc., a health technology company, today announced the closing of a $235 million private financing round. The investment includes participation from new investors Perceptive Advisors, MSD Capital, and Koch Strategic Platforms, a subsidiary of Koch Industries, existing investors Johnson & Johnson Innovation – JJDC, Inc. (JJDC), Decheng Capital, CAVU Ventures, ACME Capital, and others.
- In March, the FDA granted Emergency Use Authorization for
Read More
Perceptive Advisors Closes $515M Early-Stage Biotech Fund
What You Should Know:
- Perceptive Advisors and biotech accelerator Xontogeny, focused on seed investment, incubation and collaboration, have raised their second venture capital fund, the Perceptive Xontogeny Ventures Fund II (PXV Fund II), totaling an over-subscribed $515 million. This more than triples Assets Under Management to more than $700M in less than two years.
- The
Read More
Axtria Secures $150M for AI-Enabled Platform for Life Sciences
What You Should Know:
- Bain Capital Tech Opportunities has announced a $150 million growth investment in Axtria, a global cloud software and data analytics provider that helps life sciences businesses bring therapeutics to market faster – which will help Axtria to consolidate its strong position in cloud software and artificial intelligence by rapidly expanding its suite of life sciences-focused SaaS platforms.
- With the life sciences and healthcare
Read More
CVS Health Expands Return Ready Vaccine Clinics to Accommodate Small Business & Schools
What You Should Know:
- Today, CVS Health announced that it will expand Return Ready, the company’s comprehensive COVID-19 solution that helps employers and schools return and maintain healthy communities, with scalable vaccine clinics to accommodate smaller workplaces/communities and schools given the Food and Drug Administration (FDA) emergency use authorization of the Pfizer-BioNTech vaccine for adolescents ages 12 to 15.
- Small businesses and schools with more than
Read More
Florence Raises $80M to Expand Connectivity Platform for Clinical Trials
What You Should Know:
- Florence, a site connectivity platform in clinical trials, today announced the close of a $80 million Series C funding round led by Insight Partners, a global venture capital and private equity firm focused on investing in ScaleUp software companies. Existing investors Fulcrum Equity Partners, Bee Partners, and Flashpoint also joined this round.
- Based in Atlanta, GA, Florence is a global leader in remote connectivity and electronic document workflow management for
Read More
